glp-1 agonist. Comparing Ozempic, Wegovy and Other Drugs GLP-1 and Dual GIP/GLP-1 Agonists

This hormone regulates blood sugar and reduces appetite

The FDA has approved certain medications (Victoza, Ozempic, Trulicity) for cardiovascular risk reduction in patients with established cardiovascular disease and type 2 diabetes, and Wegovy for cardiovascular risk reduction in adults with established cardiovascular disease who have overweight or obesity

Why are investors betting on combination therapies like CagriSema over single-drug approaches

doi: 10.1111/jgh.12271

Glucagon-like peptide type 1 receptor agonistsIncretin effect and systemic effects of glucagon-like peptide type 1 and its agonists The incretin effect describes the phenomenon whereby oral glucose elicits higher (23 times) insulin secretory responses than does intravenous glucose.25 This is due to incretin hormones, such as GLP-1 or glucose-dependent insulinotropic polypeptide, which stimulate insulin secretion in response to food intake